AI4Biotech Executive Session – Agentic AI in Life Sciences: From Hype to Strategic Deployment
An in-person executive event for decision-makers in biotech, pharma and research who need to strategically understand and responsibly deploy AI agents, not just learn about them.
Featuring a Thought Leader Dialogue with Dr. Anna Bauer-Mehren (Roche).
Agentic AI is quickly moving from a technical topic to a strategic leadership priority.
This exclusive one-day Executive Session provides decision-makers in biotech, pharma, and biomedical research a structured orientation, realistic assessments, and a pragmatic roadmap for introducing Agentic AI into their organizations. It is delivered by AGENTIC GmbH, an advisory team combining deep AI expertise with decades of life science leadership experience.
The day concludes with an inspiring impulse and fireside chat with thought leader Dr. Anna Bauer-Mehren (Roche), followed by networking with finger food and drinks.
Participation is limited to ~25 executives to ensure a highly interactive and personal exchange. Organizations may also benefit from sending small teams (2–3 participants, at a reduced rate), to include multidisciplinary team perspectives during the session.
👉 Register now! AI4Biotech Executive Session – Agentic AI in Life Sciences: From Hype to Strategic Deployment – BioM
Brief Program Overview
Morning | ORIENT – Expert Insights & Strategic Framing
Noon | EXCHANGE – Facilitated Discussion & Networking over Lunch
Afternoon | APPLY – Hands-On Use Case Design & Prioritization
Evening | CHALLENGE – Thought Leader Discourse & Networking
Who Should Attend
This Executive Session is designed for senior leaders and decision-makers from biotech, pharma and diagnostics companies, research institutions, investors, ecosystem partners and policy stakeholders who are seeking strategic orientation and practical readiness for generative and agentic AI in R&D, operations and innovation across the life science sector.
Interested in attending as a team? Benefit from reduced prices for 2 or more participants per company/institute.
Key Outcomes
- Clear understanding of Agentic AI – what is real, what is hype, what matters
- Identified value levers tailored to your organization
- Prioritized use cases aligned with strategy & readiness
- A 90-day action plan including governance and pilot scoping
- Board-ready positioning for internal stakeholders
Led by Experts from AGENTIC GmbH
Andreas Waldert, Managing Director – AI strategy, agentic systems, analytics transformation
David Pilarek, Industry Advisor – 20+ years of leadership experience across the pharma value chain (former European Life Science Head, NTT Data; former Partner, Merck Inhouse Consulting)